Genetic analysis of the pathogenic molecular sub-phenotype interferon-alpha identifies multiple novel loci involved in systemic lupus erythematosus

Genes and Immunity

Volumn 16, Issue 1, 2015, Pages 15-23

  Kariuki, S N ^a   Ghodke Puranik, Y ^b   Dorschner, J M ^b   Chrabot, B S ^c   Kelly, J A ^d   Tsao, B P ^e   Kimberly, R P ^f   Alarcon Riquelme M E ^d,g   Jacob, C O ^h   Criswell, L A ⁱ   Sivils, K L ^d   Langefeld, C D ^j   Harley, J B ^k   Skol, A D ^a   Niewold, T B ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f University of Alabama at Birmingham   (United States)

^g UNIVERSITY OF GRANADA   (Spain)

^h UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j WAKE FOREST UNIVERSITY   (United States)

^k CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANKYRIN; ANKYRIN REPEAT DOMAIN 44; CYCLIC GMP DEPENDENT PROTEIN KINASE; PURINE NUCLEOSIDE PHOSPHORYLASE; UNCLASSIFIED DRUG; CYCLIC GMP DEPENDENT PROTEIN KINASE 1; PRKG1 PROTEIN, HUMAN;

ANCESTRY GROUP; ANKRD44 GENE; ARTICLE; AUTOIMMUNE DISEASE; BIOINFORMATICS; CONTROLLED STUDY; DENDRITIC CELL; EUROPEAN; GENE; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; HUMAN; IMMUNE RESPONSE; INTERFERON PRODUCTION; NATURAL KILLER CELL; PATHOGENESIS; PHENOTYPE; PLEKHF2 GENE; PNP GENE; PRIORITY JOURNAL; PRKG1 GENE; SYSTEMIC LUPUS ERYTHEMATOSUS; CASE CONTROL STUDY; CAUCASIAN; FEMALE; GENE REGULATORY NETWORK; GENETICS; IMMUNOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; CYCLIC GMP-DEPENDENT PROTEIN KINASE TYPE I; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE REGULATORY NETWORKS; HUMANS; INTERFERON-ALPHA; LUPUS ERYTHEMATOSUS, SYSTEMIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PURINE-NUCLEOSIDE PHOSPHORYLASE;

EID: 84921605360     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2014.57     Document Type: Article

References (52)

1. Harley JB, Kelly JA, Kaufman KM. Unraveling the genetics of systemic lupus erythematosus. Springer Semin Immunopathol 2006; 28: 119-130.
2. Ko K, Koldobskaya Y, Rosenzweig E, Niewold TB. Activation of the interferon pathway is dependent upon autoantibodies in African-American SLE patients, but not in European-American SLE patients. Front Immunol 2013; 4: 309.
3. Sanchez E, Comeau ME, Freedman BI, Kelly JA, Kaufman KM, Langefeld CD et al. Identification of novel genetic susceptibility loci in African American lupus patients in a candidate gene association study. Arthritis Rheum 2011; 63: 3493-3501.
4. Ko K, Franek BS, Marion M, Kaufman KM, Langefeld CD, Harley JB et al. Genetic ancestry, serum interferon-alpha activity, and autoantibodies in systemic lupus erythematosus. J Rheumatol 2012; 39: 1238-1240.
5. Niewold TB, Hua J, Lehman TJ, Harley JB, Crow MK. High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus. Genes Immun 2007; 8: 492-502.
6. Graham RR, Kozyrev SV, Baechler EC, Reddy MV, Plenge RM, Bauer JW et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 2006; 38: 550-555.
7. Harley JB, Alarcon-Riquelme ME, Criswell LA, Jacob CO, Kimberly RP, Moser KL et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 2008; 40: 204-210.
8. Remmers EF, Plenge RM, Lee AT, Graham RR, Hom G, Behrens TW et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 2007; 357: 977-986.
9. Gateva V, Sandling JK, Hom G, Taylor KE, Chung SA, Sun X et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 2009; 41: 1228-1233.
10. Rullo OJ, Tsao BP. Recent insights into the genetic basis of systemic lupus erythematosus. Ann Rheum Dis 2013; 72(Suppl 2): ii56-ii61.
11. Ghodke-Puranik Y, Niewold TB. Genetics of the type I interferon pathway in systemic lupus erythematosus. Int J Clin Rheumatol 2013; 8: 657-669.
12. Kim K, Brown EE, Choi CB, Alarcon-Riquelme ME, Kelly JA, Glenn SB et al. Variation in the ICAM1-ICAM4-ICAM5 locus is associated with systemic lupus erythematosus susceptibility in multiple ancestries. Ann Rheum Dis 2012; 71: 1809-1814.
13. Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 2001; 294: 1540-1543.
14. Hooks JJ, Moutsopoulos HM, Geis SA, Stahl NI, Decker JL, Notkins AL. Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med 1979; 301: 5-8.
15. Weckerle CE, Franek BS, Kelly JA, Kumabe M, Mikolaitis RA, Green SL et al. Network analysis of associations between serum interferon-alpha activity, autoantibodies, and clinical features in systemic lupus erythematosus. Arthritis Rheum 2011; 63: 1044-1053.
16. Petri M, Singh S, Tesfasyone H, Dedrick R, Fry K, Lal P et al. Longitudinal expression of type I interferon responsive genes in systemic lupus erythematosus. Lupus 2009; 18: 980-989.
17. Niewold TB, Clark DN, Salloum R, Poole BD. Interferon alpha in systemic lupus erythematosus. J Biomed Biotechnol 2010; 2010: 948364.
18. Niewold TB. Interferon alpha-induced lupus: proof of principle. J Clin Rheumatol 2008; 14: 131-132.
19. Niewold TB, Swedler WI. Systemic lupus erythematosus arising during interferonalpha therapy for cryoglobulinemic vasculitis associated with hepatitis C. Clin Rheumatol 2005; 24: 178-181.
20. Kariuki SN, Kirou KA, MacDermott EJ, Barillas-Arias L, Crow MK, Niewold TB. Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-alpha in lupus patients in vivo. J Immunol 2009; 182: 34-38.
21. Niewold TB, Kelly JA, Flesch MH, Espinoza LR, Harley JB, Crow MK. Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients. Arthritis Rheum 2008; 58: 2481-2487.
22. Robinson T, Kariuki SN, Franek BS, Kumabe M, Kumar AA, Badaracco M et al. Autoimmune disease risk variant of IFIH1 is associated with increased sensitivity to IFN-alpha and serologic autoimmunity in lupus patients. J Immunol 2011; 187: 1298-1303.
23. Agik S, Franek BS, Kumar AA, Kumabe M, Utset TO, Mikolaitis RA et al. The autoimmune disease risk allele of UBE2L3 in African American patients with systemic lupus erythematosus: a recessive effect upon subphenotypes. J Rheumatol 2012; 39: 73-78.
24. Eliopoulos E, Zervou MI, Andreou A, Dimopoulou K, Cosmidis N, Voloudakis G et al. Association of the PTPN22 R620W polymorphism with increased risk for SLE in the genetically homogeneous population of Crete. Lupus 2011; 20: 501-506.
25. Mavragani CP, Niewold TB, Moutsopoulos NM, Pillemer SR, Wahl SM, Crow MK. Augmented interferon-alpha pathway activation in patients with Sjogren's syndrome treated with etanercept. Arthritis Rheum 2007; 56: 3995-4004.
26. Niewold TB, Wu SC, Smith M, Morgan GA, Pachman LM. Familial aggregation of autoimmune disease in juvenile dermatomyositis. Pediatrics 2011; 127: e1239-e1246.
27. Maiti AK, Kim-Howard X, Motghare P, Pradhan V, Chua KH, Sun C et al. Combined protein-and nucleic acid-level effects of rs1143679 (R77H), a lupus-predisposing variant within ITGAM. Hum Mol Genet 2014; 23: 4161-4176.
28. Kariuki SN, Franek BS, Kumar AA, Arrington J, Mikolaitis RA, Utset TO et al. Traitstratified genome-wide association study identifies novel and diverse genetic associations with serologic and cytokine phenotypes in systemic lupus erythematosus. Arthritis Res Ther 2010; 12: R151.
29. Koldobskaya Y, Ko K, Kumar AA, Agik S, Arrington J, Kariuki SN et al. Geneexpression-guided selection of candidate loci and molecular phenotype analyses enhance genetic discovery in systemic lupus erythematosus. Clin Dev Immunol 2012; 2012: 682018.
30. Farkas L, Beiske K, Lund-Johansen F, Brandtzaeg P, Jahnsen FL. Plasmacytoid dendritic cells (natural interferon-alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am J Pathol 2001; 159: 237-243.
31. Hagberg N, Berggren O, Leonard D, Weber G, Bryceson YT, Alm GV et al. IFN-alpha production by plasmacytoid dendritic cells stimulated with RNA-containing immune complexes is promoted by NK cells via MIP-1beta and LFA-1. J Immunol 2011; 186: 5085-5094.
32. Rullo OJ, Woo JM, Wu H, Hoftman AD, Maranian P, Brahn BA et al. Association of IRF5 polymorphisms with activation of the interferon alpha pathway. Ann Rheum Dis 2010; 69: 611-617.
33. Orstavik S, Natarajan V, Tasken K, Jahnsen T, Sandberg M. Characterization of the human gene encoding the type I alpha and type I beta cGMP-dependent protein kinase (PRKG1). Genomics 1997; 42: 311-318.
34. Snyder FF, Jenuth JP, Mably ER, Mangat RK. Point mutations at the purine nucleoside phosphorylase locus impair thymocyte differentiation in the mouse. Proc Natl Acad Sci USA 1997; 94: 2522-2527.
35. Toro A, Grunebaum E. TAT-mediated intracellular delivery of purine nucleoside phosphorylase corrects its deficiency in mice. J Clin Invest 2006; 116: 2717-2726.
36. Lipsky PE. Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity. Nat Immunol 2001; 2: 764-766.
37. Sasaki Y, Iseki M, Yamaguchi S, Kurosawa Y, Yamamoto T, Moriwaki Y et al. Direct evidence of autosomal recessive inheritance of Arg24 to termination codon in purine nucleoside phosphorylase gene in a family with a severe combined immunodeficiency patient. Hum Genet 1998; 103: 81-85.
38. Markert ML. Purine nucleoside phosphorylase deficiency. Immunodefic Rev 1991; 3: 45-81.
39. Lee-Kirsch MA, Gong M, Chowdhury D, Senenko L, Engel K, Lee YA et al. Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet 2007; 39: 1065-1067.
40. Al-Mayouf SM, Sunker A, Abdwani R, Abrawi SA, Almurshedi F, Alhashmi N et al. Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus. Nat Genet 2011; 43: 1186-1188.
41. Namjou B, Kothari PH, Kelly JA, Glenn SB, Ojwang JO, Adler A et al. Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort. Genes Immun 2011; 12: 270-279.
42. Lin WJ, Yang CY, Lin YC, Tsai MC, Yang CW, Tung CY et al. Phafin2 modulates the structure and function of endosomes by a Rab5-dependent mechanism. Biochem Biophys Res Commun 2010; 391: 1043-1048.
43. Li C, Liu Q, Li N, Chen W, Wang L, Wang Y et al. EAPF/Phafin-2, a novel endoplasmic reticulum-associated protein, facilitates TNF-alpha-triggered cellular apoptosis through endoplasmic reticulum-mitochondrial apoptotic pathway. J Mol Med (Berl) 2008; 86: 471-484.
44. Stefansson B, Ohama T, Daugherty AE, Brautigan DL. Protein phosphatase 6 regulatory subunits composed of ankyrin repeat domains. Biochemistry 2008; 47: 1442-1451.
45. Chio A, Schymick JC, Restagno G, Scholz SW, Lombardo F, Lai SL et al. A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis. Hum Mol Genet 2009; 18: 1524-1532.
46. Kosoy R, Nassir R, Tian C, White PA, Butler LM, Silva G et al. Ancestry informative marker sets for determining continental origin and admixture proportions in common populations in America. Hum Mutat 2009; 30: 69-78.
47. Jabs WJ, Hennig C, Zawatzky R, Kirchner H. Failure to detect antiviral activity in serum and plasma of healthy individuals displaying high activity in ELISA for IFNalpha and IFN-beta. J Interferon Cytokine Res 1999; 19: 463-469.
48. Hua J, Kirou K, Lee C, Crow MK. Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies. Arthritis Rheum 2006; 54: 1906-1916.
49. Feng X, Han D, Kilaru BK, Franek BS, Niewold TB, Reder AT. Inhibition of interferonbeta responses in multiple sclerosis immune cells associated with high-dose statins. Arch Neurol 2012; 69: 1303-1309.
50. Yeung KY, Ruzzo WL. Principal component analysis for clustering gene expression data. Bioinformatics 2001; 17: 763-774.
51. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575.
52. Whitlock MC. Combining probability from independent tests: the weighted Z-method is superior to Fisher's approach. J Evol Biol 2005; 18: 1368-1373.